Funding in medical technology, October 2014

Funding for medical technologies in October 2014 totaled $332 million, led by the $59 million funding of Ivantis, Inc., and the $55 million funding of PureTech.

Below are the top fundings for the month:

Company, fundingProduct/technology
Ivantis, Inc., has raised $58.87 million of a $71.37 million round of fundng according to a regulatory filingStent-based treatment to lower intraocular pressure in glaucoma
PureTech has raised $55 million in a round of funding according to the companyMedical device and other technologies spanning treatments in immunology, metabolism, neuroscience, drug delivery and consumer digital health
VytronUS, Inc., has raised $31.6 million in a Series B round of funding according to the companyIntegrated imaging and ultrasound ablation for treatment of cardiac arrhythmias
Respicardia, Inc., has raised $25.09 million in a round of funding according to a regulatory filingElectrical pulse-based implant treatment for sleep apnea
Magnus Life Science (Magnus Life Ltd) has raised £15.5 million ($24.96 million) in a round of funding according to regulatory filingDevice and non-device technologies based on dynamics of bloodflow
Medrobotics Corp. has raised $20 million in a preferred stock offering according to the companyComputer-assisted access and visualization system for minimally invasive robotic surgery

For the complete list of medtech fundings in October 2014, see link. For a historical list of the fundings in medtech, by month, since 2009, see link.

Leave a Reply